Stockreport

CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) [Yahoo! Finance]

BNP PARIBAS SPONS ADR  (BNPQY) 
NASDAQ:AMEX Investor Relations: invest.bnpparibas.com/en
PDF CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ) , the specialty pharmaceutical company that develops products for emergency situations based on its proprietary ZEN [Read more]